Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Univercells
company
About
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions
- 51 - 100
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €50M
- Industries
- Biotechnology,Health Care,Manufacturing
- Founded date
- Jan 1, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%.Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€50M
Univercells has raised a total of
€50M
in funding over 2 rounds. Their latest funding was raised on
Feb 18, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2020 | Series Unknown | €50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Univercells is funded by 1 investors.
Kohlberg Kravis Roberts
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Kohlberg Kravis Roberts
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
